Thursday 17 July 2014              13:30 – 15:00
Track 3 - Advances in GI pharmacology: New approaches to upper & lower GI ulcers & inflammation

Chairs: Sandor Szabo & Koji Takeuchi

New challenges in GI pharmacology
Sandor Szabo

Prophylactic Effects of Prostaglandin E2 on NSAID-Induced Enterophathy: Role of EP4 Receptors in its Protective and Healing-Promoting Effects
Koji Takeuchi

Development of new, safe NSAIDs
Lenard Lichtenberger

The clinical reality of preventing & treating gastroduodenal ulcers
Gaetano Iaquinto

Experimental colitis alters expression of serotonin receptors and transient receptor potential vanilloid type 1 (TRPV1) channels leading to visceral hypersensitivity in mice
Shunji Horie

Irritable bowel syndrome (IBS) is stress sensitive: do targeting stress mediators will offer new therapeutic venues?
Yvette Tache